NextMeds vs Pallas Health
An in-depth comparison of two leading GLP-1 Providers
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

NextMeds
Best for: semaglutide at $79/month, 59% under the register median
Visit NextMeds →
Pallas Health
Best for: knowing which pharmacy fills the vial — it names Belmar Pharmacy
Visit Pallas Health →Two GLP-1 Providers chasing the same patients, trading off price, geography and what lands in the box differently. On our scoring, NextMeds opens cheaper — $79/mo against $199, and Pallas Health is where most people should begin. What follows: the prices, what each plan actually covers, the six-dimension score, where each one is weak, and who should pick which.
Pricing
NextMeds
Compounded Semaglutide Membership, drug included when prescribed, alongside telehealth visits, a care coach, a dietitian and shipping. $79 is the month-to-month rate read from the pricing section on 2026-08-14. The site headline reads 'from $49/mo': that is the 12-month prepaid term divided down, not a monthly price, and the ladder between them is 3-month $76, 6-month $73, 12-month $49. A summer promotion was running with a stated end of August 20, so $79 may itself be discounted.
Compounded Tirzepatide Membership, drug included when prescribed, alongside telehealth visits, a care coach, a dietitian and shipping. $109 is the month-to-month rate read from the pricing section on 2026-08-14. The advertised 'GLP-1 + GIP: $95' is the 12-month prepaid term divided down; the ladder is 3-month $105, 6-month $100, 12-month $95. A summer promotion was running with a stated end of August 20, so $109 may itself be discounted.
Pallas Health
$139 for the first month, then $597 every 12 weeks, which Pallas advertises as a $199/mo average. Same price at every dose. Provider care and check-ins included.
$179 for the first month, then $897 every 12 weeks, advertised as a $299/mo average. Same price at every dose.
What’s included
NextMeds
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
In the price
Pallas Health
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Score breakdown
Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.
NextMeds
9.2/10
Pallas Health
8.0/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
Features & Coverage
| Feature | NextMeds | Pallas Health |
|---|---|---|
| Starting Price | ✓$79/mo | $199/mo |
| Features | 8 features | 8 features |
| States Available | 50 | ✓51 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | ✓ Yes | ✓ Yes |
| FDA Warnings | None | None |
About NextMeds
Membership is a single flat monthly charge, and inside it sit free shipping, a registered dietitian holding a license, a care coach working 1:1, telehealth visits and the drug itself where one is prescribed. Insurance is not billed. A free assessment online goes to a licensed provider, who adds a phone or video consult in states that demand one, then prescribes if it fits. Compounding pharmacies within the Next Meds network, all licensed, ship. Auto-renewal does not exist, cancellation is open, and all 50 states can order compounded tirzepatide and semaglutide.
Read our full NextMeds review →About Pallas Health
$199 and $299 a month are the averages on the compounded plans, with messaging, check-ins and provider care folded in, no membership charged on the side, and the figure unchanged at every dose. Mounjaro, Zepbound, Ozempic and Wegovy sell under their brand names next to compounded tirzepatide and semaglutide. Brentmoor, Inc. is the operator. Disclosure is unusually thorough here: NPIs you can verify against two named advising physicians, Lion MD as clinical partner, six pharmacy partners named, and all 50 states plus DC covered.
Read our full Pallas Health review →Pros & Cons
NextMeds
What we like
- Semaglutide at $79 a month, 58% below the $189 median for the same drug and form across this register
- Tirzepatide at $109 a month, 59% below the $267 median for the same drug and form across this register
- Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
- The monthly figure covers medication, consult, shipping, coaching
- Coverage is published for all 50 states
- No FDA warning letter matched this operator when we searched our enforcement register
Watch-outs
- No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Pallas Health
What we like
- Semaglutide at $199 a month, within the normal band around this register's $189 median for the same drug and form
- Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
- The monthly figure covers medication, consult, shipping
- Coverage is published for all 50 states
- Names 6 dispensing pharmacies, which most sellers in this register do not do
- No FDA warning letter matched this operator when we searched our enforcement register
Watch-outs
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Pallas Health is the one we would pick, particularly on knowing which pharmacy fills the vial — it names Belmar Pharmacy. NextMeds is a real alternative if semaglutide at $79/month, 59% under the register median is what you are after — the six-dimension breakdown and the prices below are what to weigh against your own case.
Choose NextMeds if…
You want semaglutide at $79/month, 59% under the register median and an opening price near $79 a month.
Choose Pallas Health if…
You want knowing which pharmacy fills the vial — it names Belmar Pharmacy and an opening price near $199 a month.
Ready to start? Vetted GLP-1 providers
Vetted telehealth providers that prescribe GLP-1 online.
No insurance needed · vetted by our editors
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Telos Rx
Starting below a standard dose, with microdose tiers
From $49/mo
Get started →MyDrHank
An oral route if you will not self-inject
From $25/mo
Get started →SkinnyRx
Starting below a standard dose, with microdose tiers
From $149.25/mo
Get started →NextMeds vs Pallas Health: FAQ
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring NextMeds and Pallas Health head-to-heads in the same category.
- NextMeds vs Trimi Health
- NextMeds vs Embody
- NextMeds vs He & She MD
- Pallas Health vs Lean Meds
- Pallas Health vs bmiMD
- Pallas Health vs CoreAge Rx
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.